Alterity Therapeutics Limited (PRNAF)
OTCMKTS · Delayed Price · Currency is USD
0.0070
+0.0040 (133.33%)
At close: Sep 23, 2025
Alterity Therapeutics Market Cap
Alterity Therapeutics has a market cap or net worth of $63.39 million as of November 7, 2025. Its market cap has increased by 492.23% in one year.
Market Cap
63.39M
Enterprise Value
37.16M
Revenue
3.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since March 28, 2000, Alterity Therapeutics's market cap has increased from 31.63M to 63.39M, an increase of 100.41%. That is a compound annual growth rate of 2.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 63.39M | 140.67% |
| Dec 31, 2024 | 26.34M | 96.98% |
| Dec 29, 2023 | 13.37M | -18.58% |
| Dec 30, 2022 | 16.42M | -55.31% |
| Dec 31, 2021 | 36.75M | -24.34% |
| Dec 31, 2020 | 48.57M | 296.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 674.13M |
| Glass House Brands | 579.39M |
| Northwest Biotherapeutics | 374.83M |
| American Oncology Network | 326.52M |
| Nika Pharmaceuticals | 311.89M |
| Silence Therapeutics | 310.80M |
| CytoDyn | 308.64M |